We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Hold RH Stock in Your Portfolio Now
Read MoreHide Full Article
RH’s (RH - Free Report) new membership model is improving its brand image, streamlining operations and enhancing customer experience. The company’s efforts to redesign supply chain network and rationalize product offerings bode well. However, dependence on foreign manufacturing and imports makes it vulnerable to uncertain macro conditions.
Meanwhile, this Zacks Rank #3 (Hold) company’s shares have returned 29% in the past six months, against the industry’s decline of 15.8%. Also, estimates for the current year and the next moved up 3% and 13.4%, respectively, over the last 30 days, reflecting analysts’ confidence in the company’s future earnings.
Key Positives
A new membership model and a more efficient operating platform bode well for RH. The model has enhanced the brand, streamlined operations and improved customer experience. The company made significant progress in redesigning its operating platform, simplifying reverse logistics as well as outlet model and reducing inventory by 30% in 2017 compared with the year-ago period.
Now that 95% of the company’s core business is driven by members, it is focusing on the expansion of its chain of restaurants within its stores. The company opened RH Toronto and RH West Palm, its second and third locations with integrated cafés, wine vaults and barista bars. In fact, revenues from RH West Palm are expected to increase significantly in 2018. The company will continue to aggressively invest toward a strong hospitality platform.
In 2018, the company is expected to consistently focus on execution, architecture and cash. It also plans on opening four new Galleries in 2018, which include three integrated cafés, wine vaults and barista bars. Such initiatives are expected to enhance overall customer experience and drive demand.
Hurdles
RH’s business is highly dependent on global trade. A significant portion of its merchandise is sourced from outside the United States, the majority of which originated from China. Thus, any economic or regulatory changes in the foreign countries will dent the company’s business. Implementation of tariffs may lead to an increase in cost of goods sold and hike product prices. This might also lead to a decline in consumer demand, which is likely to mar the company’s financial performance.
The company’s first-quarter 2018 sales guidance is soft. Overall revenues expectation for 2018 is also modestly below estimates. Net revenues are expected to grow 5-7% compared with 14% growth in 2017.
Bottom Line
Though RH is expected to generate soft sales growth this year, analysts are optimistic about the company’s efforts to generate strong cash flow and expect margins to counter lower sales.
The company plans to shift focus toward revenue growth in fiscal 2019, by accelerating its real estate transformation and returning to its product and business expansion strategy, which has been on hold owing to the transformation drive. Net revenue growth is expected to reaccelerate to a range of 8-12% in 2019.
Dine Brands is expected to witness 22.7% earnings growth in 2018.
Earnings for Arcos Dorados are expected to grow 23.7% in 2019.
Ruth's Hospitality’s 2018 earnings are projected to grow 22.7%.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
Here's Why You Should Hold RH Stock in Your Portfolio Now
RH’s (RH - Free Report) new membership model is improving its brand image, streamlining operations and enhancing customer experience. The company’s efforts to redesign supply chain network and rationalize product offerings bode well. However, dependence on foreign manufacturing and imports makes it vulnerable to uncertain macro conditions.
Meanwhile, this Zacks Rank #3 (Hold) company’s shares have returned 29% in the past six months, against the industry’s decline of 15.8%. Also, estimates for the current year and the next moved up 3% and 13.4%, respectively, over the last 30 days, reflecting analysts’ confidence in the company’s future earnings.
Key Positives
A new membership model and a more efficient operating platform bode well for RH. The model has enhanced the brand, streamlined operations and improved customer experience. The company made significant progress in redesigning its operating platform, simplifying reverse logistics as well as outlet model and reducing inventory by 30% in 2017 compared with the year-ago period.
Now that 95% of the company’s core business is driven by members, it is focusing on the expansion of its chain of restaurants within its stores. The company opened RH Toronto and RH West Palm, its second and third locations with integrated cafés, wine vaults and barista bars. In fact, revenues from RH West Palm are expected to increase significantly in 2018. The company will continue to aggressively invest toward a strong hospitality platform.
In 2018, the company is expected to consistently focus on execution, architecture and cash. It also plans on opening four new Galleries in 2018, which include three integrated cafés, wine vaults and barista bars. Such initiatives are expected to enhance overall customer experience and drive demand.
Hurdles
RH’s business is highly dependent on global trade. A significant portion of its merchandise is sourced from outside the United States, the majority of which originated from China. Thus, any economic or regulatory changes in the foreign countries will dent the company’s business. Implementation of tariffs may lead to an increase in cost of goods sold and hike product prices. This might also lead to a decline in consumer demand, which is likely to mar the company’s financial performance.
The company’s first-quarter 2018 sales guidance is soft. Overall revenues expectation for 2018 is also modestly below estimates. Net revenues are expected to grow 5-7% compared with 14% growth in 2017.
Bottom Line
Though RH is expected to generate soft sales growth this year, analysts are optimistic about the company’s efforts to generate strong cash flow and expect margins to counter lower sales.
The company plans to shift focus toward revenue growth in fiscal 2019, by accelerating its real estate transformation and returning to its product and business expansion strategy, which has been on hold owing to the transformation drive. Net revenue growth is expected to reaccelerate to a range of 8-12% in 2019.
Stocks Worth a Look
A few better-ranked stocks in the Zacks Retail-Wholesale sector are Dine Brands Global, Inc. (DIN - Free Report) , Arcos Dorados Holdings Inc. (ARCO - Free Report) and Ruth's Hospitality Group, Inc. . While Dine Brands sports a Zacks Rank #1 (Strong Buy), the other two stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Dine Brands is expected to witness 22.7% earnings growth in 2018.
Earnings for Arcos Dorados are expected to grow 23.7% in 2019.
Ruth's Hospitality’s 2018 earnings are projected to grow 22.7%.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>